ProCure Treatment Centers Selects International Vendor to Equip Proton Therapy Center in Oklahoma

(Bloomington, Ind.—January 8, 2007) ProCure Treatment Centers, Inc., which is developing a network of cancer treatment centers across the United States to deliver FDA approved proton radiotherapy, today announced it has selected Belgium-based IBA (Ion Beam Applications S.A.: Reuters IOBAt.BR and Bloomberg IBAB.BB) to supply the proton therapy equipment, valued at approximately $50 million, for its first private practice proton therapy center slated to begin construction in early 2007 in Oklahoma City.

ProCure Treatment Centers has partnered with Radiation Medicine Associates and Radiation Oncology Associates, two leading radiation oncology practices in Oklahoma City to bring proton therapy, the most advanced form of external radiation therapy for treating cancer available today, to Oklahoma where it was determined there was a significant need for increased availability of the treatment. Cancer is the second leading cause of death in Oklahoma with an estimated 18,500 new cases diagnosed every year.

“We are very excited by our partnership with ProCure, RMA and ROA,” said Pierre Mottet, IBA’s chief executive officer. “Proton therapy is increasingly accepted as the next big advance in cancer treatment using radiation. ProCure has developed a unique concept to make this new technology available to community hospitals and private practices based on a smart financing package and integrated approach. We expect that their concept will be key in providing access to proton therapy for many hospitals, physicians and patients in the U.S.”

The four treatment room, 55,000 sq foot ProCure Proton Therapy Center in Oklahoma Cityis scheduled for completion in 2009. It will provide access to proton therapy for an additional 1,500 cancer patients per year in the U.S.

“ProCure has a unique approach bringing this important technology into mainstream America,” said Hadley Ford, CEO of ProCure. “We are excited to be working with IBA to help bring about the vision of proton therapy for the patients of Oklahoma and other communities. It validates the vision of Dr. William C. Goad who has championed the need for proton therapy in private practice settings.”

Indiana-based ProCure Treatment Centers, Inc. was founded in 2005 by Dr. John Cameron, who played a pivotal role in the creation of one of the nation’s first proton therapy treatment facilities, the Midwest Proton Radiotherapy Institute in Bloomington, Indiana. ProCure provides management support and a proven model for the complete design, construction, operation and maintenance of proton therapy treatment centers, in an effort to make proton therapy accessible to everyone who would benefit from the treatment.

For more information about ProCure Treatment Centers, Inc., please visit www.ProCure.com. To learn more about IBA, visit www.iba-worldwide.com.

###

 

Download PDF

Media Contacts:

Renzi Stone
Saxum Strategic Communications
rstone@
saxumcommunications.com

405-608-0445 or
405-202-5068

Paul-Emmanuel Goethals IBA Director, Corporate Business Development & Investor Relations
Paul-emmanuel.goethals
@iba-group.com

Phone: +32 10 47 58 16

 

 
 
 

© ProCure Treatment Centers, Inc.

The Web site for ProCure Treatment Centers, Inc., its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient or clinical relationship. Please remember that this information should not substitute for a visit or a consultation with a healthcare provider. The views or opinions expressed in the resources provided do not necessarily reflect those of ProCure Treatment Centers, Inc. By using this Web site, you accept these: Terms of Use. Please read our Privacy Statement.
 
 
 
ProCure